Evidence map›Paper›PMID 33979967›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2021

[Treatment and prevention of bile duct injury in hepatocellular carcinoma after transarterial chemoembolization].

J H He, H Sun, C X Wu

Open access · greenAbstract read
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. [Clinical study on early predictors of concurrent bile duct injury following TACE in patients with liver cancer].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  3. [Applied anatomical study and clinical application of the caudate lobe boundary and ductal system of the liver].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J H HeDepartment of Hepatobiliary, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
H SunInstitute of Viral Hepatitis, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
C X WuDepartment of Hepatobiliary, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Dalian Medical University · CN

Funding

National Natural Science Foundation of China 81871608
6 · The paper itself

Abstract

Transarterial chemoembolization is the first choice for patients with advanced stage liver cancer who are not apt for surgical resection. In clinical practice, rare and serious complications occur occasionally, and bile duct injury is one of the complications after transarterial chemoembolization. Therefore, understanding its mechanism and high-risk factors can reduce the occurrence of bile duct injury, and early detection and treatment can significantly improve the prognosis. This article summarizes the clinical research progress of bile duct injury in hepatocellular carcinoma after transarterial chemoembolization.

Indexed as

Carcinoma, HepatocellularChemoembolization, TherapeuticLiver NeoplasmsBile DuctsHumansPrognosisRetrospective StudiesTreatment OutcomeBile duct injuryHepatocellular carcinomaTranscatheter arterial chemoembolization

Identifiers

PMID33979967
PMCPMC12813794
OpenAlexW3162744640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.